- Home
- / Baxter International
- / Revenue
Baxter InternationalHeader placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Annual Revenue ($)
Baxter International revenue was $11.67 b in FY, 2020
Quarterly Revenue ($)
Annual Growth Rate (%)
Revenue Breakdown
Business Segment
Geographic Segment
Baxter International revenue breakdown by business segment: 7.7% from Advanced Surgery, 7.7% from Clinical Nutrition, 19.0% from Pharmaceuticals, 24.6% from Medication Delivery, 32.0% from Renal Care and 9.0% from Other
Baxter International revenue breakdown by geographic segment: 53.6% from Americas, 26.1% from EMEA and 20.2% from APAC
| FY, 2019 | FY, 2018 | FY, 2017 | |
|---|---|---|---|
| Other | $485 m | $510 m | $455 m |
| Acute Therapies | $535 m | $517 m | $456 m |
| Advanced Surgery | $877 m | $800 m | $707 m |
| Clinical Nutrition | $872 m | $877 m | $882 m |
| Pharmaceuticals | $2.16 b | $2.09 b | $1.88 b |
| Medication Delivery | $2.8 b | $2.67 b | $2.7 b |
| Renal Care | $3.64 b | $3.66 b | $3.48 b |
| FY, 2019 | FY, 2018 | FY, 2017 | |
|---|---|---|---|
| Americas | $6.09 b | $5.96 b | $5.72 b |
| EMEA | $2.97 b | $2.96 b | $2.73 b |
| APAC | $2.3 b | $2.21 b | $2.11 b |
Need Data?
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.